Diabetes mellitus in Parkinson`s disease patients
نویسندگان
چکیده
منابع مشابه
Liver disease in patients with diabetes mellitus.
Liver function tests were assessed in 60 unselected out-patient diabetics stabilized on insulin or oral hypoglycaemic agents. Routine liver function tests, particularly plasma concentrations of gamma-glutamyl transpeptidase and alkaline phosphatase were elevated occasionally but rarely to more than twice the upper limit of normal. There was no correlation between measures of diabetic control an...
متن کاملFrequency of diabetes mellitus in patients with skin tags
Background and aim: Diabetes mellitus is a metabolic disease with multiple complications. Skin tag is a pedunculated papule, which is more common in women and has been suggested as a cutaneous marker of diabetes mellitus. The aim of this study was to determine the frequency of diabetes mellitus in patients with skin tags.Materials and methods: This descriptive study was...
متن کاملAutomatic, unsupervised classification of dyskinesia in patients with Parkinsons Disease
One of the characteristic symptoms of patients with Parkinson Disease (PD) is a rigidity of movement. These symptoms disappear after administration of Levodopa. However, the long-term use of levodopa causes involuntary movements (dyskinesia). A proper diagnosis requires an automatic, unsupervised method for the detection and classification of levodopa induced dyskinesia. The main problem, howev...
متن کاملDiabetes Mellitus in the Elderly
Nach einer Einleitung und Diskussion tiber die Eingenschaften der diabetischen Krankheiten wurde ausflihrlich trber die Aetiologie und Pathophysiologie der Zuckerankheiten,insbesondere der Altersdiabetis,gesprochen.Nach der symptomalogie der Diabetis haben wir die ncueste Einteilung der Zuckerkrankheiten genannt und die Untcrsuchungsmethoden,die heute Uhlich sind,erwahnt;dazu wurden unsere M...
متن کاملManagement of diabetes mellitus in patients with chronic kidney disease
Glycemic control is essential to delay or prevent the onset of diabetic kidney disease. There are a number of glucose-lowering medications available but only a fraction of them can be used safely in chronic kidney disease and many of them need an adjustment in dosing. The ideal target hemoglobin A1c is approximately 7 % but this target is adjusted based on the needs of the patient. Diabetes con...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Scripta Scientifica Medica
سال: 2013
ISSN: 1314-6408,0582-3250
DOI: 10.14748/ssm.v45i1.346